WHO asks to unify criteria for recognition of vaccines for travelers

All vaccines anticovid on the emergency list of the WHO or other regulators of drugs must be worth a traveler to be recognized as fully immunized, even in countries where some of these vaccines is not yet approved, claimed on Thursday, July 1, 2021, the Organization World Health Organization (WHO).

In a statement along with other agencies with which it develops the Covax vaccine distribution program, the agency urges “all governments regional, national and local ”that recognize as fully vaccinated those who have received vaccines that have been considered safe by the WHO.

The ready from emergency approved by the WHO includes vaccines of Pfizer-BioNTech, Moderna, AstraZeneca, Janssen, Sinovac Y Sinopharm, but for example the last two, developed in China and widely distributed in developing regions such as Africa O Latin America, are not approved by European or US regulators.

The appeal comes at a time when many countries are opening up to the arrival of international travelers, Due to the reduction gradual number of cases in the last two months, although the rise in delta variant in some areas it has made contagions weekly have risen again globally.

“Any measure that only allows people protected by some vaccines approved by the WHO to benefit from the reopening of the travels create a dual system, increasing global divisions around vaccines and exacerbating the inequalities“, Warns the WHO.

In addition, “it will negatively impact the increase of the economies who are suffering more ”, underlines, referring to developing countries, a statement that is also signed by the GAVI Vaccine Foundation and the United Nations Children’s Fund (Unicef), WHO partners in Covax.

–